Lv5
1040 积分 2023-03-27 加入
Abstract 48: T cell-specific in vivo transduction with preclinical candidate KLN-1010 generates BCMA directed CAR T cells with potent anti-multiple myeloma activity
1个月前
已关闭
Antigen identification and high-throughput interaction mapping by reprogramming viral entry
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
2个月前
已完结
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
3个月前
已完结
Engineering CAR-T Cells for Next-Generation Cancer Therapy
4个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
5个月前
已完结
In vivo site-specific engineering to reprogram T cells
6个月前
已完结
Recent advances in therapeutic cancer vaccines
6个月前
已完结
皖公网安备34019202002308
